Table 1. Mutations in the human GlyT2 gene (SLC6A5) in patients with hyperekplexia.
Patient | Global origin |
Parental origin |
Sequence change | Exon | Mutation | Subcellular location |
Glycine transport |
Mechanism |
---|---|---|---|---|---|---|---|---|
1 | Canada | Paternal Maternal |
C1131A G1294T + Ins[T]1295 | 7 8 |
Y377X
V432F+fs97 |
Cytoplasmic
Cytoplasmic |
Abolished
Abolished |
In frame stop codon, protein truncation Missense plus frameshift, protein truncation |
2 | USA | Unknown | A1472G C1888T |
9 13 |
Y491C
Q630X |
Cell surface Cytoplasmic |
Abolished
Abolished |
Missense, functionally inert In frame stop codon, protein truncation |
3 | Australia | Unknown | delC{319-324} T1444C |
2 9 |
P108L+fs25
W482R |
Cytoplasmic Cell surface |
Abolished
Abolished |
Missense plus frameshift, protein truncation Missense, glycine binding site (W482R) |
4 | Netherlands | Paternal Maternal |
C916G A1526G |
5 10 |
L306V
N509S |
Cell surface Cell surface |
Abolished in
L306V+N509S |
Missense, sodium binding site (N509S), compound recessive |
5 | Netherlands | Paternal Maternal |
C1274T C1274T |
8 8 |
T425M
T425M |
Cell surface | Abolished | Missense, functionally inert |
6 | UK | Maternal | T1530G | 10 | S510R | Cytoplasmic | Abolished | Missense mutation, S510R forms large intracellular aggregates, dominant-negative |